Supplemental Legend from Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Legend Correlative
DOI: 10.1158/1078-0432.22473821 Publication Date: 2023-04-01T20:41:03Z